Related by context. All words. (Click for frequent words.) 57 wider 55 Narrower 50 Broader 49 Widening 49 Broadened 47 Expanded 46 Expanding 45 Increased 45 Improved 45 Broadening 44 Tighter 44 Widened 44 widen 43 Widest 42 Broaden 41 Narrow 41 Widen 41 Bigger 41 Longer 40 widened 40 Misinformation Campaign 40 Tougher 40 widens 39 Diminishes 39 Shrinking 39 Slowing Growth 39 Monetary Easing 39 Speedier 39 Strengthen 39 Riskier Than 39 narrower 39 Diamyd Medical Diamyd 39 Extended 39 Poses Risk 39 Overestimated 38 Wider Than 38 Enlarging 38 Quantifies 38 Significant 38 Widens 38 Increasing 38 Get Mixed Reviews 38 Quarrel Over 38 Extend 38 Extensive 38 Inadequate 38 Firmer 38 Help Stabilize 38 Wants Bigger 38 Closer Ties 38 broader 38 Grow Faster 38 Debt Contagion 38 Eroding 38 Shift Toward 38 Scaling Back 37 Narrowed 37 Urges Stronger 37 Expansive 37 Beefing Up 37 Yield Spreads 37 Seen Boosting 37 widening 37 Could Cripple 37 Amid Slowdown 37 Reforms Needed 37 Narrowing 37 Reverses Loss 37 Restructure Debt 37 Reinforce 37 Simpler 37 Diminish 37 Reexamine 37 Making Inroads 37 Robust 37 Easing 37 Sees Positive 37 Substantial 37 Browser Ballot 37 Modifiable 37 Wide Ranging 37 Restrictive 37 Negligible 37 Ramp Up 36 Faces Difficult 36 Widespread 36 Wide 36 broaden 36 Boost Profits 36 Contagion Fears 36 Interest Rate Increases 36 Lower Than Expected 36 Extending 36 Lowered 36 Adequate 36 Deeper 36 Outweigh 36 Cut Greenhouse Gases 36 Changes 36 Strengthens 36 Rising Interest Rates 36 Drug Makers 36 Lag Behind 36 Longer Term 36 Delicate Balancing Act 36 Tighter Controls 36 Seeks Stronger 36 Broadest 36 Lags 36 Entry Into 36 Enlarges 36 Slower 36 Alters 36 Debt Woes 36 Gloomy Outlook 36 Fatten Up 36 Arthritis Drugs 36 Safer 36 Harmonise 36 Increase 36 Outweighs 36 Debt Worries 36 Bolster 36 German Fin Min 36 Higher 36 Break Deadlock 36 Thinner 36 Less Than Feared 36 Woes Remain 36 Setback 36 Huge 36 Skilled Immigrants 36 Broadens 36 Stands Ready 36 Hormonal Contraceptives 36 Deeply Flawed 36 Unapproved 36 Sustain Growth 36 Reduced 36 Disputed 36 Warranted 36 Lengthen 36 #.#.#.#.# [004] 36 Sweeping Changes 36 Possible 36 Growth Slowing 36 Leaner 36 Draw Criticism 36 Expand 36 Deeper Into 36 Satellite Radio Merger 36 Gains Traction 36 Crimped 36 Debate Intensifies 36 Superfast Broadband 36 Awaits Approval 36 Tariff Cuts 36 Profit Misses 36 Slight Gain 36 Varied 36 Expensive Than 35 Sees Possible 35 Faces Uncertain 35 Pared Down 35 Desirable 35 Strategic Implications 35 Differing Views 35 Prove Itself 35 Tightened 35 Prevent Obesity 35 Slump Update2 35 Weak 35 Suspend Enrichment 35 Flu Vaccine Shortage 35 Prospects Dim 35 Re Examine 35 Few Surprises 35 Stronger Warnings 35 Weakening Economy 35 Biased Against 35 Enhanced 35 Downwards 35 Little Changed Before 35 Lukewarm Response 35 Talks Underway 35 Fatter 35 Renewed 35 Regulatory Approvals 35 Extend Reach 35 Economy Grows Faster Than 35 Enlarged 35 Higher Than Expected 35 Antitrust Probe 35 EU Accession 35 Spark Debate 35 Bogs Down 35 Determine Fate 35 Negatively Affect 35 Smoother 35 Could Worsen 35 Regains Ground 35 Exceed Previous 35 Diminished 35 Report Suggests 35 Study Reinforces 35 Tightening 35 Drastically Cut 35 Distorting 35 Rheumatoid Arthritis Drug 35 Less Invasive 35 wide 35 Adjusts 35 Advances 35 Instability 35 Scrutinized 35 Jump Sharply 35 Little Changed Ahead 35 Reshaped 35 Frozen Conflicts 35 Stop Uranium Enrichment 35 Rehear 35 Clears Path 35 Decline Update3 35 Down Sharply 35 Per Cent Increase 35 Might Affect 35 Dollar Dips 35 Fiscal Stimulus 35 Adversely Affect 35 Blurs 35 Regulatory Hurdles 35 Didier Dutronc 35 Mend Ties 35 Downward Pressure 35 FDA Panel Recommends 35 Higher Interest Rates 35 EU#.# Billion [001] 35 Strengthening 35 Sees Weaker 35 Frets About 35 Fewer Side Effects 35 Underpin 35 Accounting Errors 35 Bleak Outlook 35 Dramatic Increase 35 Expand Scope 35 Strengthened 35 Gathers Pace 35 Net Neutrality Debate 35 GBP#.# Billion [001] 35 Minimal 35 Heavier 35 Normalize 35 Gathers Steam 35 Greenspan Warns 35 Probe Update1 35 Fatty Foods 35 Doubts Linger 35 Experts Urge 35 Benefits Outweigh 35 Revised Upward 34 Weaken 34 Reshape 34 Beats Views 34 Loosens 34 Clearer 34 Brain Tumours 34 Cancels Planned 34 EURO CORP 34 Stricter 34 Face Tougher 34 Radically Change 34 Pose Challenges 34 Spreads Widen 34 Vary Widely 34 Lack 34 Tighten 34 Apfn 34 Remain Intact 34 Funding Shortfall 34 Drug Approvals 34 Friendlier 34 Altered 34 Seek Wider 34 Tread Carefully 34 Exerts 34 Slips Slightly 34 Sustained Growth 34 Undercut 34 Fading Fast 34 Boost 34 Spell Doom 34 Calcium Vitamin D 34 European Stocks Pare 34 Dramatically Reduce 34 Pre empt 34 Better Than Expected 34 Could Pave Way 34 Rates Decline 34 Worries Ease 34 Draws Nearer 34 Antitrust Complaint 34 Slight Gains 34 Airline Mergers 34 Drug Coated Stents 34 Sees Huge 34 Probe Widens 34 Weighty 34 Downside Risks 34 Econ Crisis 34 Impairs 34 Deteriorated 34 Slowdown Update1 34 Ups Pressure 34 Hinged 34 Osteoarthritis Pain 34 Seeks Wider 34 Gives Cautious 34 Erase Gains 34 Pneumonia Vaccine 34 Anemia Drugs 34 Gaining Strength 34 Keep Rates Unchanged 34 Attract Buyers 34 Deadline Arrives 34 Lessened 34 Poses Risks 34 Leaked Cables 34 Outside Mkts 34 Expand Coverage 34 Uneven 34 Rejects Takeover 34 Inappropriate 34 Increases 34 Debt Buyback 34 Stunted Growth 34 Slims Down 34 Slight 34 Ticks Higher 34 Majority Ownership 34 Misaligned 34 Diversifies 34 Reassessing 34 Dollar Slides 34 Improve Quality 34 Nearly Doubled 34 Yield Advantage 34 Political Upheaval 34 Postive 34 Airport Body Scanners 34 Remains Unclear 34 2Q Loss 34 Shows Slight 34 Bigger Than Expected 34 Disparity Between 34 Tougher Stance 34 Leans Toward 34 Softer 34 Reevaluating 34 Statistically Significant 34 Drop Sharply 34 Watchdog Probes 34 Loosened 34 Genetically Modified Foods 34 Selective 34 Narrows Loss 34 Interest Rate Concern 34 Leaked Documents 34 Spreads Across 34 Mixed Reaction 34 Spells Out 34 Significant Improvements 34 GoldCore Update 34 Shifts Toward 34 Pose Problems 34 Statin Drugs 34 Interest Rate Fears 34 Painkiller Abuse 34 Stimulative 34 MAIN FACTS 34 Raises Hackles 34 Shifting 34 Expects 1Q 34 Too Costly 34 Must Rethink 34 Continues Upward 34 Approach Needed 34 Revises 34 Lagging Behind 34 Interest Rate Cuts 34 FY# Adj 34 Posts Unexpected 34 Sees Weak 34 Technological Advances 34 Refines 34 Weighs Heavily 34 Unsettle 34 Stiffer 34 Reignited 34 Emerging Mkts 34 Focuses Attention 34 Interest Rate Hikes 34 Weaker 34 Profit Surged 34 Face Hurdles 34 Ignites Debate 34 Doubts Remain 34 Tightening Concerns 34 Modest Growth 34 Swine Flu Fears 34 Pose Risks 34 Remain Unchanged 34 validity enforceability 34 Growing Faster Than 34 Rate Cuts 34 Limiting 34 Settle Dispute Over 34 Beats Forecasts 34 Stronger 34 greater 34 Worries Linger 34 Patent Lawsuit 34 Unique Challenges 34 Translate Into 34 Makes Headway 34 Gov'ts 34 Destabilize 34 CDS Spreads 34 Losses Widen 34 Emissions Cuts 34 Stir Controversy 34 Networked Devices 34 Resolve Differences 34 Stronger Than Expected 34 Losses Narrow 34 Receives Unsolicited 34 Stays Strong 34 Obstacles Remain 34 Expects 2Q 34 Weakens 34 Cuts Threaten 34 Intensify 34 Lawsuit Dismissal 34 Heightened 34 Narrows 2Q 34 Resume Uranium Enrichment 34 Deflates 34 Intensified 34 Invest Heavily 34 Softens 34 Decline Sharply 34 broadening 34 Trade Imbalances 34 Broadly Lower 34 Guantánamo Detainees 34 Study Shows Significant 34 Costs Update2 34 Subprime Woes 34 Costs Update1 34 Improve Patient 34 Successful Conclusion 34 Options Expensing 34 Skewed 34 Under Scrutiny 34 Psychographic 33 Less Likely 33 Gives Upbeat 33 Exponential Growth 33 Subprime Worries 33 Receptive 33 Various Types 33 Expands 33 Gaining Steam 33 Annan Urges 33 Deteriorating 33 Heads Toward 33 Finds Itself 33 GBP#.# Billion [002] 33 Face Obstacles 33 Cites Positive 33 Supply Disruption 33 Ease 33 Helps Ensure 33 Rally Falters 33 Sagging Economy 33 Ambivalent About 33 Hesitant 33 Roil 33 Nuke Bomb 33 Antidepressants Linked 33 Study Explores 33 Fiscal Woes 33 Probe Finds 33 Missile Shield 33 Reinforces Its 33 Less Costly 33 Unveils Ambitious 33 Sagging 33 Stocks Pare Gains 33 Below Expectations 33 Sinks Into 33 Raises Forecast 33 Could Hinder 33 Recession Fears 33 Antipsychotic Drugs 33 Trim Losses 33 Subprime Concern 33 Cash Infusion 33 Loss Narrowed 33 Loss Widened 33 Heartburn Drugs 33 Could Harm 33 Risky Assets 33 Destabilization 33 Lessen 33 Actively Seeking 33 Scraps Dividend 33 Profit Little Changed 33 Worse Than Expected 33 Boost Economy 33 Downward 33 Range Bound 33 Closer Ties With 33 Tighten Border 33 Interrogation Tactics 33 Further Strengthens 33 Loss Shrinks 33 Concerns Remain 33 Battle Intensifies 33 Investors Await Fed 33 Increases Commitment 33 Nudges 33 Concerns Weigh 33 Investors Await 33 Bailout Package 33 Rise Update2 33 FTC Clears 33 Positive 33 Urgent Issues 33 Make Headway 33 Liberalisation 33 Poll Shows Support 33 Misconceptions 33 Pivotal Role 33 Reinforces 33 Feds Propose 33 Execs Discuss 33 Heightens 33 Piracy Suit 33 Prostate Cancer Survival 33 Intersex Fish 33 Reaffirm Commitment 33 Wiping Out 33 Files Complaint Over 33 Going Smoothly 33 Inch Up 33 Significantly Expand 33 Potash Bid 33 Opinions Vary 33 Overhauls 33 Inch Toward 33 Abortion Pill 33 Epilepsy Drug 33 Bleak Future 33 Higher Margins 33 Judicious 33 Store Closures 33 Sees Wider 33 Weight Loss Drug 33 Rethinks 33 Missile Defenses 33 Overstepping 33 impair FPL 33 Favorable Ruling 33 Outstrip 33 Faces Tough 33 Poorer 33 Lower 33 Shows Weakness 33 Envoy Urges 33 Enlargement 33 Wider Range 33 Reject Proposal 33 Cheaper 33 Downside Risk 33 Sour Economy 33 Questions Loom 33 Puzzling 33 Posts Wider Than Expected 33 Stock Tumbles 33 preferably conversant 33 Poses Challenge 33 Plays Down 33 Modifies 33 Liver Toxicity 33 Problematic 33 Toll Hikes 33 Sportier 33 Advisers Urge 33 Ad Supported Mobile 33 Reports 4Q Loss 33 Generic Zocor 33 Lessening 33 Varying 33 Speculation Mounts 33 Beefed Up 33 Settle Antitrust 33 Refocuses 33 Ease Limits 33 Sharply Lower 33 Fourfold 33 Leaders Agree 33 FSB Draghi 33 Gender Specific 33 Cost Efficiencies 33 GLOBAL EXCERPTS 33 Effective Approach 33 Safer Than 33 Divergent 33 Qualms 33 Carve Out 33 Remain Robust 33 Stepped Up 33 Strict 33 Tame Inflation 33 Phasing Out 33 Treads Lightly 33 Connecting Talents 33 Drags Down 33 GBP#.# Million [002] 33 Conditionality 33 Than Feared 33 Finish Mixed 33 Dominant Position 33 Hinges 33 Could Weaken 33 Move Quickly 33 Newsview 33 Feasible 33 Interest Rate Hike 33 Have Begun 33 Cuts 33 Edges Toward 33 Obese Teens 33 Could Endanger 33 Deploy Troops 33 Prevent Child 33 Improvements 33 1Q Loss 33 Quadruples 33 Racial Ethnic 33 Risk Averse 33 Could Undermine 33 Wanes 33 Weigh Heavily 33 Cautious Approach 33 Anti Malarial 33 Ironed Out 33 Decline 33 Record Levels 33 Really Necessary 33 Concerns 33 Debated 33 Larger Than Expected 33 Constrain 33 Acne Drug 33 Being Studied 33 Climate Pact 33 Bird Flu Pandemic 33 Modestly Higher 33 3Q Loss Narrows 33 More Than Doubled 33 Leave Rates Unchanged 33 Feds Urge 33 Complicate 33 Posts Modest 33 Not Created Equal 33 Steams Ahead 33 Drift Lower 33 Blood Pressure Drug 33 Anticompetitive 33 Dictates 33 Wider Loss 33 Person Says Update1 33 Overstates 33 Structural Changes 33 Heroin Addicts 33 Tremendous Growth 33 End Sharply Lower 33 Passenger Screening 33 Likelier 33 Sharply Higher 33 Smaller Than Expected 33 Reconsidering 33 Promote Healthy 33 Whole Genome Sequencing 33 Panel Advises 33 Resolve Dispute Over 33 Fails Miserably 33 Shrug Off 33 Crisis Eases 33 Blemished 33 Bury Hatchet 33 Misrepresented 33 MARKET COMMENT London 33 Lifts FY# 33 Elbit Systems Awarded 33 Clearest 33 Could Trigger 33 Cholesterol Drug 33 Futures Slip 33 Matches Expectations 33 Tame Inflation Data 33 Differs From 33 Diverge 33 Reconfirms 33 Move Toward 33 FY# Profit Declines 33 Negative Effects 33 Extend Declines 33 Device Makers 33 2Q Loss Widens 33 Interferes With 33 Posts Narrower 33 Draws Fire 33 Lessens 33 Tightens 33 Showed Significant 33 Further Validates 33 Official Criticizes 33 Informal 33 Be Scrapped 33 Modest Rebound 33 Gains Update2 33 Wins Approval 33 Bone Graft Substitutes 33 Sees Progress 33 Harsher 33 Cautions Against 33 Slightly Weaker 33 Lennar Swings 33 Device Maker 33 Motorists Warned 33 Sufficient 33 Loses Ground 33 Genetic Defect 33 Admits Mistake 33 Fight Malaria 33 Forge Ahead 33 Protesters Decry 33 Declines 33 Voids 33 1Q Loss Narrows 33 Prostate Cancer Vaccine 33 Could Threaten 33 Biggest Problem 33 Midday Trading 33 Raising Debt Ceiling 33 Alternate 33 Underpins 33 Modest 33 Resistant TB 33 Complicates 33 Gets Subpoena 33 Tweaks 33 Rates Unchanged 33 Traders Pare Bets 33 Complaint Handling 33 Fine Tunes 33 Economic Woes 33 Pros Cons 33 Panel Faults 33 Sentence Sought 33 Liberalise 33 Reconsider 33 Provide Clues 33 Ease Restrictions 33 1bps tighter 33 Wary Eye 33 Opportunities Exist 33 Repay Debt 33 Are Little Changed 33 Deteriorate 33 Slowdown Concern 33 Major Step Toward 33 Revises Guidance 33 Netbook Shipments 33 Still Exist 33 Completes Offering 33 Deeper Cuts 33 Counteract 33 Fully Prepared 33 Revamp 33 Timeframe 33 Waning 33 Allay Fears 33 Results Reflect 33 Shares Tumble 33 Head Scarf Ban 33 Stiffens 33 Envoy Warns 33 Insufficient 33 Posts 1Q Profit 33 Overstated 33 TheFXSpot 33 Serious Flaws 33 Mostly Higher 33 Slight Rise 33 Magnifies 33 Hagee Endorsement 33 Up Sharply 33 Antitrust Scrutiny 33 Patent Ruling 33 Fend Off 33 Fears Grow 33 Boosts Profit 33 Favourable 33 Op Ed Contributors 33 Aggressive Expansion 33 Panel Suggests 33 Antiretroviral Drug 33 Reclassifies 33 Diminishing 33 Default Swaps 33 Flat Panels 33 Inflation Worries 33 Redraws 33 Wobbles 33 Poorer Countries 33 Play Crucial Role 33 Shortened 33 Liberalize 33 Minimizes 33 Worries Weigh 33 Narrowly Mixed 33 Debate Rages 32 thereby blunting 32 MALVERN WEST 32 Cut Carbon Emissions 32 Poverty Inequality 32 Radiation Exposure 32 Cholesterol Lowering Drugs 32 Restates 32 Seen Steady 32 Restate Results 32 Drops Sharply 32 Withdrawn 32 Provide Unprecedented 32 Creeping Into 32 MARKET COMMENT European 32 Deepens 32 Share Buybacks 32 Sells Remaining 32 Misread 32 Detrimental 32 Midmorning Trading 32 Antitrust Case 32 Small Footprint 32 Realigned 32 Destabilizing 32 Homogenous 32 Rises Sharply 32 Rapidly Evolving 32 Margin Expansion 32 OECD Gurria 32 Flight Disruptions 32 Economists React 32 Continue Slide 32 Boosts 32 1Q Profit Dips 32 Yen Retreats 32 Gets Thumbs Down 32 Reclassify 32 Euro Changeover 32 Slightly Higher 32 Broadens Its 32 Feels Pressure 32 EUR# Billion 32 Underlines 32 Breast Ovarian Cancer 32 Advantageous 32 Deepening 32 Smoother Ride 32 Weight 32 Reinvigorates 32 Dwindling 32 Untapped Potential 32 Sees Rebound 32 Lighter 32 Cautious Outlook 32 Alito Nomination 32 Hits Lowest Level 32 Curtailed 32 Short Lived 32 Formally Launches 32 Exec Quits 32 Active 32 Practicalities 32 Backfiring 32 Takes Step Toward 32 Euro Slips 32 Practicable 32 Pose Serious 32 broadened 32 Risky 32 Orc Software Orc 32 LAW TALK 32 Announces Expanded 32 Carotid Artery Stenting 32 Clock Ticks 32 Caution Urged 32 Straddles 32 Rise Modestly 32 Gets Boost From 32 Overhang 32 Reasserts 32 Reduces Size 32 Converging 32 Renewed Effort 32 Growing Threat 32 4Q Loss 32 Junk Status 32 Vaccine Autism 32 Talks Progressing 32 Rejig 32 Cotton Subsidies 32 Reports Wider Loss 32 Stocks Pare Losses 32 Structural Reforms 32 Study Debunks 32 Debt Concern 32 Sees Higher 32 Reaffirms Outlook 32 CardioDynamics Announces 32 Refinance Debt 32 Wider Than Expected 32 Racial Divide 32 Weakening 32 Attitude Towards 32 Favorable 32 Trade Pacts 32 Remain Committed 32 Exceed Forecast 32 EUR# Mln 32 Improve Ties 32 Takeover Talk 32 Proposed 32 Coordinated 32 Legally Binding 32 Lifts Restrictions 32 Post Menopausal 32 Key Enabler 32 Credit Woes 32 Sees Slower Growth 32 Radical Overhaul 32 Sees Substantial 32 Complies With 32 Shifts 32 Steadying 32 Body Scans 32 Capitalise 32 Burgeoning 32 Patent Dispute 32 Fluctuate 32 Accelerate Growth 32 Immediately Accretive 32 Reconfirm 32 Underscore 32 Mixed Feelings 32 Rationalise 32 Expresses Concern Over 32 Underwrite 32 Revolutionise 32 Evaluates 32 Mixed Ahead 32 Deepen 32 Hits Bump 32 Must Defend 32 Localized 32 Elective Surgery 32 Improving 32 Negotiators Agree 32 Polls Indicate 32 Cervical Dysplasia 32 Booster Shot 32 Specific 32 Pdt 32 Deepened 32 Gaps Remain 32 Eased 32 Delist From 32 Narrower Loss 32 Nonprescription 32 Tightens Rules 32 Dents 32 Shrugs Off 32 Formalize 32 Worker Shortage 32 Make Inroads